Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Biological Drug Products

Development and Strategies
BuchGebunden
744 Seiten
Englisch
Wiley & Sonserschienen am29.11.20131. Auflage
This book overviews the fundamental aspects, challenges, and strategies for developing a variety of biological drugs -- a large and growing segment of the pharmaceutical industry. Contributing authors discuss the development process, safety and clinical assessments, manufacturing, regulatory and intellectual property issues.mehr
Verfügbare Formate
BuchGebunden
EUR194,50
E-BookEPUB2 - DRM Adobe / EPUBE-Book
EUR167,99
E-BookPDF2 - DRM Adobe / Adobe Ebook ReaderE-Book
EUR167,99

Produkt

KlappentextThis book overviews the fundamental aspects, challenges, and strategies for developing a variety of biological drugs -- a large and growing segment of the pharmaceutical industry. Contributing authors discuss the development process, safety and clinical assessments, manufacturing, regulatory and intellectual property issues.
Details
ISBN/GTIN978-1-118-14889-1
ProduktartBuch
EinbandartGebunden
Erscheinungsjahr2013
Erscheinungsdatum29.11.2013
Auflage1. Auflage
Seiten744 Seiten
SpracheEnglisch
Gewicht1115 g
Artikel-Nr.28963757

Inhalt/Kritik

Inhaltsverzeichnis
Dedication Preface Part 1. General Aspects 1 Chapter 1. An Overview of Discovery and Development Process For Biologics 3 Heather H. Shih, Paula Miller and Douglas C. Harnish Chapter 2. Nonclinical Safety Assessment of Biologics, Including Vaccines 31 Liangbiao George Hu, David W. Clarke Chapter 3 Clinical Assessment of Biologics Agents 57 Lesley Ann Saketkoo, Shikha Mittoo and Luis R. Espinoza Chapter 4. Key Regulatory Guidelines for Development of Biologics In The U.S. And Europe 75 Richard Kingham, Gabriela Klasa and Krista Hessler Carver Chapter 5. Landscape and Consideration of Intellectual Property for Development Of Biosimilars 111 Srikumaran Melethil Chapter 6. Scientific Aspects of Sterility Assurance, Sterility, Asepsis, and Sterilization 133 James E. Akers and James P. Agalloco Part 2. Proteins/Peptides 163 Chapter 7. Cell Cell Culture Processes in Monoclonal Antibody Production 165 Feng Li, Amy (Yijuan) Shen and Ashraf Amanullah Chapter 8. Protein/Peptide Purification and Virus Reduction 203 Beckley K. Nfor, Esteban Freydell and Marcel Ottens Chapter 9. Chemical and Genetic Modification 233 M Farys, C Ginn, G Badescu, K Peciak, E Pawlisz, H Khalili and S Brocchini Chapter 10. Analytical Characterization of Proteins/Peptides 285 Yajun Jennifer Wang and Brian Hosken Chapter 11. Protein/Peptide Formulation Development 323 Satoshi Ohtake and Wei Wang Chapter 12. Regulatory Strategies and Lessons in the Development Of Biosimilars 367 Umang S. Shah Part 3. Vaccines 409 Chapter 13. Vaccine Development - History, Current Status and Future Trends 411 Leo Van Der Pol and Jean-Pierre Amorij Chapter 14. Role and Application of Adjuvants and Delivery Systems in Vaccines 437 Rajesh K. Gupta Chapter 15. Methods for Characterizing Proteins in Aluminum Adjuvant Formulations 469 Martinus A.H. Capelle, Emilie Poirier and Tudor Arvinte Part 4. Novel Biologics 487 Chapter 16. The State Of The Art and Future of Gene Medicines 489 Frank Jacobs, Stephanie C. Gordts and Bart De Geest Chapter 17. Nucleic Acid Vaccines 531 Rachel Buglione-Corbett, John Suschak, Shixia Wang and Shan Lu Chapter 18. Multifunctional Polymeric Nano-Systems for Rna Interference Therapy 569 Arun Iyer, Shanthi Ganesh, Qiong L. Zhou and Mansoor Amiji Chapter 19. Advent and Maturation of Regenerative Medicine 601 Abner M. Mhashilkar and Anthony Atala Part 5. Product Administration/Delivery 629 Chapter 20. Conventional and Novel Container Closure/Delivery Systems 631 Joseph Wong and Mahesh V. Chaubal Chapter 21. Controlled-Release Systems for Biologics 655 Mayura Oak, Rhishikesh Mandke, Buddhadev Layek, Gitanjali Sharma and Jagdish Singh Chapter 22. Routes of Delivery for Biological Drug Products 677 Darrell J. Irvine, Xingfang Su and Brandon Kwong INDEX 725mehr
Kritik
"Thus, it will be a valuable resource for both novice and expert alike." (ChemMedChem, 1 October 2014)mehr

Autor

WEI WANG, PhD, is a Research Fellow for Pfizer BioTherapeutics Pharmaceutical Sciences. In addition, Dr. Wang is Adjunct Professor in the School of Pharmacy and Health Sciences at the University of the Pacific.

MANMOHAN SINGH, PhD, is Head of Technical Development at Novartis Vaccines and Diagnostics. Dr. Singh has authored over 120 peer-reviewed manuscripts, reviews, and book chapters in the area of vaccine formulations and adjuvant research. He is also an Adjunct Professor at the Eshelman School of Pharmacy at University of North Carolina, Chapel Hill.